Literature DB >> 25720524

PPARγ suppressed Wnt/β-catenin signaling pathway and its downstream effector SOX9 expression in gastric cancer cells.

Xiyun Ren1, Dongyou Zheng, Fang Guo, JingJing Liu, Bing Zhang, Hailin Li, Wenjing Tian.   

Abstract

Wnt signaling pathway activation plays a critical role in biological processes of tumor progression. SOX9 belongs to the sry-related high-mobility group box (SOX) family and is a key transcription factor in the development and differentiation of multiple cell lineages. The purpose of this study was to investigate whether suppression of Wnt signaling pathway by PPARγ gene affects target SOX9 gene expression. The pEGFP-N1-PPARγ overexpression recombinant plasmid was structured by molecular biology technology. The overexpression plasmid and empty vector pEGFP-N1 were transfected into three types of human gastric cancer cell lines, with different levels of differentiation, MKN-28, SGC-7901 and BGC-823. The PPARγ, β-catenin and SOX9 mRNA levels and proteins were examined by real-time PCR and Western blot analysis. The pEGFP-N1-PPARγ recombinant plasmid was constructed and transfected into MKN-28, SGC-7901 and BGC-823 successfully. High expression of PPARγ (p < 0.05) for transfection recombinant plasmid group induced obviously decreased expression of β-catenin (p < 0.05), whereas SOX9 expression decreased significantly (p < 0.05) compared with the transfection empty vector group and normal comparison group. PPARγ can suppress β-catenin expression in Wnt signaling pathway and its downstream effector SOX9 expression in gastric cancer cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25720524     DOI: 10.1007/s12032-015-0536-8

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  22 in total

Review 1.  Wnt signaling and cancer.

Authors:  P Polakis
Journal:  Genes Dev       Date:  2000-08-01       Impact factor: 11.361

Review 2.  The many ways of Wnt in cancer.

Authors:  Paul Polakis
Journal:  Curr Opin Genet Dev       Date:  2007-02       Impact factor: 5.578

3.  The Wnt/beta-catenin signaling pathway targets PPARgamma activity in colon cancer cells.

Authors:  Emmelie A Jansson; Alexandra Are; Gediminas Greicius; I-Chun Kuo; Denise Kelly; Velmurugesan Arulampalam; Sven Pettersson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-21       Impact factor: 11.205

4.  SOX9 expression and its methylation status in gastric cancer.

Authors:  Minhua Sun; Hiroshi Uozaki; Rumi Hino; Akiko Kunita; Aya Shinozaki; Tetsuo Ushiku; Takashi Hibiya; Kimiko Takeshita; Maya Isogai; Kenzo Takada; Masashi Fukayama
Journal:  Virchows Arch       Date:  2012-02-14       Impact factor: 4.064

Review 5.  Incidence and mortality of gastric cancer in China.

Authors:  Ling Yang
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

Review 6.  Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer.

Authors:  M Jalving; J J Koornstra; S De Jong; E G E De Vries; J H Kleibeuker
Journal:  Aliment Pharmacol Ther       Date:  2005-02-15       Impact factor: 8.171

7.  A small-molecule inhibitor of Tcf/beta-catenin signaling down-regulates PPARgamma and PPARdelta activities.

Authors:  Shlomo Handeli; Julian A Simon
Journal:  Mol Cancer Ther       Date:  2008-03       Impact factor: 6.261

8.  Progression from chronic atrophic gastritis to gastric cancer; tangle, toggle, tackle with Korea red ginseng.

Authors:  Yoon Jae Kim; Jun Won Chung; So Jung Lee; Ki Seok Choi; Ju Hyun Kim; Ki Baik Hahm
Journal:  J Clin Biochem Nutr       Date:  2010-04-10       Impact factor: 3.114

9.  Peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses colonic epithelial cell turnover and colon carcinogenesis through inhibition of the beta-catenin/T cell factor (TCF) pathway.

Authors:  Toshio Fujisawa; Atsushi Nakajima; Nobutaka Fujisawa; Hirokazu Takahashi; Ikuko Ikeda; Ayako Tomimoto; Kyoko Yonemitsu; Noriko Nakajima; Chiho Kudo; Koichiro Wada; Naoto Kubota; Yasuo Terauchi; Takashi Kadowaki; Hitoshi Nakagama; Richard S Blumberg
Journal:  J Pharmacol Sci       Date:  2008-04-05       Impact factor: 3.337

10.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

View more
  13 in total

Review 1.  "Genetic scissors" CRISPR/Cas9 genome editing cutting-edge biocarrier technology for bone and cartilage repair.

Authors:  Chao Li; Yawei Du; Tongtong Zhang; Haoran Wang; Zhiyong Hou; Yingze Zhang; Wenguo Cui; Wei Chen
Journal:  Bioact Mater       Date:  2022-10-07

2.  PEDF Is Associated with the Termination of Chondrocyte Phenotype and Catabolism of Cartilage Tissue.

Authors:  P Klinger; S Lukassen; F Ferrazzi; A B Ekici; T Hotfiel; B Swoboda; T Aigner; K Gelse
Journal:  Biomed Res Int       Date:  2017-01-16       Impact factor: 3.411

Review 3.  PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis.

Authors:  Veronica Vella; Maria Luisa Nicolosi; Stefania Giuliano; Maria Bellomo; Antonino Belfiore; Roberta Malaguarnera
Journal:  Front Endocrinol (Lausanne)       Date:  2017-02-22       Impact factor: 5.555

4.  MicroRNA-27a promotes podocyte injury via PPARγ-mediated β-catenin activation in diabetic nephropathy.

Authors:  Zhanmei Zhou; Jiao Wan; Xiaoyan Hou; Jian Geng; Xiao Li; Xiaoyan Bai
Journal:  Cell Death Dis       Date:  2017-03-09       Impact factor: 8.469

Review 5.  PPARs and Mitochondrial Metabolism: From NAFLD to HCC.

Authors:  Tommaso Mello; Maria Materozzi; Andrea Galli
Journal:  PPAR Res       Date:  2016-12-27       Impact factor: 4.964

Review 6.  Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis.

Authors:  Alexandre Vallée; Yves Lecarpentier
Journal:  Front Immunol       Date:  2018-04-13       Impact factor: 7.561

7.  Comprehensive Analysis of Aberrantly Expressed ceRNA network in gastric cancer with and without H.pylori infection.

Authors:  Aining Chu; Jingwei Liu; Yuan Yuan; Yuehua Gong
Journal:  J Cancer       Date:  2019-01-29       Impact factor: 4.207

8.  CRISPRai for simultaneous gene activation and inhibition to promote stem cell chondrogenesis and calvarial bone regeneration.

Authors:  Vu Anh Truong; Mu-Nung Hsu; Nuong Thi Kieu Nguyen; Mei-Wei Lin; Chih-Che Shen; Chin-Yu Lin; Yu-Chen Hu
Journal:  Nucleic Acids Res       Date:  2019-07-26       Impact factor: 16.971

Review 9.  Targeting the Canonical WNT/β-Catenin Pathway in Cancer Treatment Using Non-Steroidal Anti-Inflammatory Drugs.

Authors:  Alexandre Vallée; Yves Lecarpentier; Jean-Noël Vallée
Journal:  Cells       Date:  2019-07-15       Impact factor: 6.600

Review 10.  SOX9 Stem-Cell Factor: Clinical and Functional Relevance in Cancer.

Authors:  Maribel Aguilar-Medina; Mariana Avendaño-Félix; Erik Lizárraga-Verdugo; Mercedes Bermúdez; José Geovanni Romero-Quintana; Rosalío Ramos-Payan; Erika Ruíz-García; César López-Camarillo
Journal:  J Oncol       Date:  2019-04-01       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.